Abstract WP015: Hypoxia and Ferroptosis: A Double Hit Driving Pericyte Dysfunction and Pathological Transition After Stroke.

Pericyte regulates cerebral blood flow, promotes blood–brain barrier (BBB) integrity, and orchestrates reparative angiogenesis after stroke. Ferroptosis, an iron-dependent regulated cell death pathway, has been implicated in driving pericyte dysfunction and pathological transition of healthy type-1 pericytes (PC1) into type-2 pericytes (PC2). PC2 are characterized by upregulated expression of inflammatory, BBB-disruptive, and phagocytic genes, as well as enhanced Alpha-smooth muscle actin (α-SMA) expression, all of which worsen stroke outcomes. We proposed that a combined insult of hypoxia and ferroptosis accelerates the PC1-to-PC2 transition and aggravates stroke injury. To test our hypothesis, Cre-lox P mice expressing rhodamine red in pericytes underwent a transient ferric chloride/middle cerebral artery occlusion (MCAO) stroke model. Ferroptosis was inhibited in select groups with the iron chelator deferoxamine (I.P 100 mg/kg body weight) daily for 5 days after stroke. Infarct size, edema, and motor function (grip strength test) were assessed post-stroke. In vitro, human brain pericytes were exposed to hypoxia with or without ferric chloride to induce ferroptosis, confirmed by lipid peroxidation assays. Immunohistochemical studies were used to assess pericyte transition (α-SMA expression), and pericyte dysfunction (BBB integrity, tight junction proteins, and pericyte capillary coverage). Results: Hypoxia increased ferroptosis-induced PC1-to-PC2 transition, evidenced by elevated α-SMA expression in pericytes (P<0.05). The combined hypoxia–ferroptosis insult markedly worsened pericyte dysfunction evidenced by reduced tight junction protein expression, increased BBB permeability, and exacerbated cerebral edema (P<0.05). These vascular impairments correlated with worsened motor performance (P<0.05). Deferoxamine treatment reversed these pathological changes in both in vivo and in vitro models. Conclusion: Hypoxia amplifies ferroptosis-driven pericyte dysfunction after stroke, accelerating the PC1-to-PC2 transition and worsening motor function outcomes. Targeting PC transition may offer a novel neurovascular protective strategy in stroke.

Authors

Institutions

Publication Details

Journal
Stroke
Published
2026-01-29
DOI
https://doi.org/10.1161/str.57.suppl_1.wp015
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract WP015: Hypoxia and Ferroptosis: A Double Hit Driving Pericyte Dysfunction and Pathological Transition After Stroke.

Sherif Hafez, Maha Coucha, Mohammed Abdelsaid, Veronica C. Hermanns
Stroke
Ferroptosis and cancer prognosis
article

Abstract WP015: Hypoxia and Ferroptosis: A Double Hit Driving Pericyte Dysfunction and Pathological Transition After Stroke.

Sherif Hafez, Maha Coucha, Mohammed Abdelsaid, Veronica C. Hermanns
article en

Abstract

Pericyte regulates cerebral blood flow, promotes blood–brain barrier (BBB) integrity, and orchestrates reparative angiogenesis after stroke. Ferroptosis, an iron-dependent regulated cell death pathway, has been implicated in driving pericyte dysfunction and pathological transition of healthy type-1 pericytes (PC1) into type-2 pericytes (PC2). PC2 are characterized by upregulated expression of inflammatory, BBB-disruptive, and phagocytic genes, as well as enhanced Alpha-smooth muscle actin (α-SMA) expression, all of which worsen stroke outcomes. We proposed that a combined insult of hypoxia and ferroptosis accelerates the PC1-to-PC2 transition and aggravates stroke injury. To test our hypothesis, Cre-lox P mice expressing rhodamine red in pericytes underwent a transient ferric chloride/middle cerebral artery occlusion (MCAO) stroke model. Ferroptosis was inhibited in select groups with the iron chelator deferoxamine (I.P 100 mg/kg body weight) daily for 5 days after stroke. Infarct size, edema, and motor function (grip strength test) were assessed post-stroke. In vitro, human brain pericytes were exposed to hypoxia with or without ferric chloride to induce ferroptosis, confirmed by lipid peroxidation assays. Immunohistochemical studies were used to assess pericyte transition (α-SMA expression), and pericyte dysfunction (BBB integrity, tight junction proteins, and pericyte capillary coverage). Results: Hypoxia increased ferroptosis-induced PC1-to-PC2 transition, evidenced by elevated α-SMA expression in pericytes (P<0.05). The combined hypoxia–ferroptosis insult markedly worsened pericyte dysfunction evidenced by reduced tight junction protein expression, increased BBB permeability, and exacerbated cerebral edema (P<0.05). These vascular impairments correlated with worsened motor performance (P<0.05). Deferoxamine treatment reversed these pathological changes in both in vivo and in vitro models. Conclusion: Hypoxia amplifies ferroptosis-driven pericyte dysfunction after stroke, accelerating the PC1-to-PC2 transition and worsening motor function outcomes. Targeting PC transition may offer a novel neurovascular protective strategy in stroke.

StrokeVol. 57(Suppl_1)
Mercer University Health Sciences Center (US), South University (US)
Good health and well-being
Openalex Percentile: Top 74%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.